Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06594224
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-09
Brief Title:
Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The local data is insufficient to directly compare IV nalbuphine versus ibuprofen among people in this region The findings of this study would add to the existing data and would be helpful for health providers to opt for a better option for postoperative pain relief following a cesarean section under general anesthesia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None